Surfing on new Duchenne data, Wave charges $175m offering | pharmaphorum

Retrieved on: 2024-09-25 11:17:25

Tags for this article:

Click the tags to see associated articles and topics

Surfing on new Duchenne data, Wave charges $175m offering | pharmaphorum. View article details on hiswai:

Excerpt

Wave Life Sciences surges on phase 2 data for exon 53-skipping drug for Duchenne muscular dystrophy that will be discussed with regulators.

Article found on: pharmaphorum.com